Evidence map›Paper›PMID 39543239›Full record

ArticleCommunications biology2024

Uncovering the arsenal of class II bacteriocins in salivarius streptococci.

Julien Damoczi, Adrien Knoops, Marie-Sophie Martou, Félix Jaumaux, Philippe Gabant, Jacques Mahillon, Jan-Willem Veening, Johann Mignolet, Pascal Hols

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Bacteriocins fromFrontiers in microbiology · 2026
    Review
  4. Journal of oral microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Genomic Sequence ofVeterinary sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julien DamocziBiochemistry and Genetics of Microorganisms, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.ORCID 0009-0001-2251-7946
Adrien KnoopsBiochemistry and Genetics of Microorganisms, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.
Marie-Sophie MartouBiochemistry and Genetics of Microorganisms, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.ORCID 0009-0009-2225-4136
Félix JaumauxSyngulon, Seraing, Belgium.
Philippe GabantSyngulon, Seraing, Belgium.
Jacques MahillonLaboratory of Food and Environmental Microbiology, Earth and Life Institute, Université catholique de Louvain, Louvain-la-Neuve, Belgium.
Jan-Willem VeeningDepartment of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-3162-6634
Johann Mignolet *Biochemistry and Genetics of Microorganisms, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.ORCID 0000-0002-3721-4307
Pascal Hols *Biochemistry and Genetics of Microorganisms, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium. Pascal.Hols@uclouvain.be.ORCID 0000-0001-8749-3650

Funding

Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) CDR J.0090.21Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) PDR T.0110.18Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) PDR T.0111.22
6 · The paper itself

Abstract

Facing the antibiotic resistance crisis, bacteriocins are considered as a promising alternative to treat bacterial infections. In the human commensal Streptococcus salivarius, the production of unmodified bacteriocins (or salivaricins) is directly controlled at the transcriptional level by quorum-sensing. To discover hidden bacteriocins, we harnessed here the unique molecular signatures of salivaricins not yet used in available computational pipelines and performed genome mining followed by orthogonal reconstitution and expression. From 100 genomes of S. salivarius, we identified more than 50 bacteriocin candidates clustered into 21 groups. Strain-based analysis of bacteriocin combinations revealed significant diversity, reflecting the plasticity of seven independent loci. Activity tests showed both narrow and broad-spectrum bacteriocins with overlapping activities against a wide panel of Gram-positive bacteria, including notorious multidrug-resistant pathogens. Overall, this work provides a search-to-test generic pipeline for bacteriocin discovery with high impact for bacterial ecology and broad applications in the food and biomedical fields.

Indexed as

BacteriocinsStreptococcus salivariusAnti-Bacterial AgentsGenome, BacterialHumansAnti-Bacterial AgentsBacteriocins

Identifiers

PMID39543239
PMCPMC11564875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.